Index S&P 500
P/E 45.80
EPS (ttm) 5.88
Insider Own 0.56%
Shs Outstand 70.14M
Perf Week 1.46%
Market Cap 18.73B
Forward P/E 68.83
EPS next Y 3.91
Insider Trans -5.20%
Shs Float 69.75M
Perf Month 0.10%
Income 420.90M
PEG 1.99
EPS next Q 1.03
Inst Own 101.98%
Short Float 4.37%
Perf Quarter 15.16%
Sales 1.98B
P/S 9.44
EPS this Y 9.31%
Inst Trans -1.55%
Short Ratio 5.46
Perf Half Y 34.37%
Book/sh 15.94
P/B 16.90
EPS next Y 21.77%
ROA 15.32%
Short Interest 3.05M
Perf Year 31.49%
Cash/sh 12.98
P/C 20.75
EPS next 5Y 23.00%
ROE 48.79%
52W Range 160.19 - 279.77
Perf YTD 24.13%
Dividend Est. -
P/FCF 82.53
EPS past 5Y 122.47%
ROI 17.01%
52W High -3.73%
Beta 1.22
Dividend TTM -
Quick Ratio 2.76
Sales past 5Y 24.75%
Gross Margin 70.01%
52W Low 68.14%
ATR (14) 7.06
Dividend Ex-Date -
Current Ratio 3.64
EPS Y/Y TTM 249.22%
Oper. Margin 15.42%
RSI (14) 59.53
Volatility 3.07% 2.41%
Employees 3000
Debt/Eq 1.25
Sales Y/Y TTM 27.42%
Profit Margin 21.22%
Recom 1.64
Target Price 287.90
Option/Short Yes / Yes
LT Debt/Eq 1.21
EPS Q/Q 53.09%
Payout 0.00%
Rel Volume 0.98
Prev Close 271.73
Sales Surprise 4.69%
EPS Surprise 38.87%
Sales Q/Q 25.70%
Earnings Nov 07 AMC
Avg Volume 558.63K
Price 269.34
SMA20 0.99%
SMA50 7.47%
SMA200 30.98%
Trades
Volume 549,055
Change -0.88%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-06-24 Initiated
Bernstein
Outperform
$300
May-30-24 Initiated
Redburn Atlantic
Buy
$235
May-07-24 Upgrade
Wolfe Research
Peer Perform → Outperform
$200
Dec-21-23 Upgrade
Robert W. Baird
Neutral → Outperform
$180 → $238
Dec-04-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$185 → $234
Oct-02-23 Upgrade
Jefferies
Hold → Buy
$260 → $240
Aug-21-23 Upgrade
Citigroup
Neutral → Buy
$273 → $265
Aug-21-23 Downgrade
Robert W. Baird
Outperform → Neutral
$320 → $219
May-30-23 Resumed
Morgan Stanley
Equal-Weight
$343
Jan-26-23 Initiated
Wolfe Research
Peer Perform
Nov-04-22 Upgrade
Piper Sandler
Neutral → Overweight
$235 → $340
Oct-18-22 Initiated
Barclays
Equal Weight
$238
Oct-12-22 Initiated
Jefferies
Hold
$260
Jul-11-22 Downgrade
Citigroup
Buy → Neutral
$310 → $250
Mar-02-22 Resumed
BofA Securities
Buy
$300
Feb-03-22 Upgrade
BTIG Research
Neutral → Buy
$320
Feb-02-22 Upgrade
UBS
Neutral → Buy
$325
Jan-31-22 Upgrade
Oppenheimer
Perform → Outperform
$300 → $275
Jul-21-21 Resumed
Cowen
Outperform
$285 → $310
May-25-21 Initiated
Barclays
Overweight
$300
Show Previous Ratings
Dec-13-24 09:50AM
Dec-11-24 02:59PM
(Investor's Business Daily)
Dec-05-24 07:19AM
Dec-04-24 04:28PM
Dec-03-24 02:51PM
(Investor's Business Daily)
09:45AM
Loading…
Nov-29-24 09:45AM
Nov-21-24 08:27AM
Nov-20-24 08:30AM
Nov-15-24 06:00AM
Nov-12-24 09:45AM
06:45AM
Nov-11-24 05:21PM
Nov-08-24 04:39PM
04:11PM
(Investor's Business Daily)
01:40PM
12:55PM
Loading…
12:55PM
(Investor's Business Daily)
06:01AM
02:27AM
Nov-07-24 05:30PM
05:15PM
04:10PM
(Associated Press Finance)
04:01PM
Nov-04-24 09:16AM
Nov-01-24 06:00AM
Oct-31-24 10:02AM
Oct-30-24 01:06PM
Oct-29-24 04:01PM
Oct-28-24 02:08PM
(Investor's Business Daily)
Oct-15-24 04:01PM
(Investor's Business Daily)
07:37AM
12:32PM
Loading…
Oct-11-24 12:32PM
Oct-10-24 09:00AM
Oct-09-24 05:53PM
08:55AM
Oct-07-24 03:04PM
Oct-01-24 08:07AM
Sep-30-24 06:00AM
Sep-12-24 01:01PM
Sep-07-24 01:16AM
Sep-05-24 07:22PM
Sep-04-24 05:00PM
Aug-30-24 10:35AM
07:20AM
01:46AM
Aug-28-24 05:25PM
Aug-27-24 05:36PM
12:48PM
11:32AM
10:08AM
08:23AM
Aug-26-24 04:20PM
01:37PM
Aug-20-24 05:25PM
05:21PM
12:11PM
06:00AM
Aug-16-24 08:57PM
Aug-14-24 03:00AM
Aug-10-24 01:04AM
Aug-09-24 05:34PM
(Morningstar Research) -8.81%
05:31PM
05:15PM
01:19PM
12:49PM
10:48AM
09:24AM
Aug-08-24 08:07PM
05:30PM
05:15PM
04:07PM
(Associated Press Finance)
04:01PM
Aug-07-24 09:02AM
Aug-05-24 09:16AM
Aug-01-24 10:01AM
Jul-26-24 09:37AM
(The Wall Street Journal)
06:00AM
Jul-18-24 12:00PM
Jul-16-24 08:45AM
Jul-08-24 06:00AM
Jun-25-24 02:32PM
Jun-24-24 04:08PM
08:36AM
08:13AM
07:13AM
Jun-21-24 06:30PM
10:59AM
08:33AM
Jun-20-24 06:05AM
06:00AM
Jun-19-24 06:02AM
Jun-17-24 07:01PM
Jun-13-24 09:24AM
Jun-11-24 07:00PM
Jun-06-24 06:19AM
May-30-24 09:59AM
May-28-24 06:00AM
May-23-24 09:50AM
May-22-24 09:45AM
May-19-24 02:08PM
May-16-24 07:42AM
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Budden Lauren Group VP, CAO and Controller Dec 10 '24 Sale 275.62 915 252,192 5,733 Dec 11 04:00 PM Budden Lauren Officer Dec 10 '24 Proposed Sale 275.62 915 252,194 Dec 10 05:18 PM BORIO LUCIANA Director Nov 12 '24 Sale 274.80 508 139,598 2,790 Nov 13 04:01 PM BORIO LUCIANA Director Nov 12 '24 Proposed Sale 274.81 508 139,602 Nov 12 04:01 PM Hopfield Jessica Director Sep 11 '24 Option Exercise 29.87 7,628 227,848 34,545 Sep 12 04:07 PM Hopfield Jessica Director Sep 11 '24 Sale 225.26 7,628 1,718,283 26,917 Sep 12 04:07 PM Scannell Timothy J Director Sep 10 '24 Sale 225.84 5,000 1,129,200 30,586 Sep 11 04:13 PM Hopfield Jessica Director Sep 11 '24 Proposed Sale 225.26 7,628 1,718,283 Sep 11 03:40 PM Field Mark N SVP & Chief Technology Officer Sep 09 '24 Sale 220.87 1,383 305,463 9,761 Sep 10 04:16 PM Budden Lauren Group VP, CAO and Controller Sep 09 '24 Sale 221.41 1,506 333,443 6,609 Sep 10 04:15 PM Scannell Timothy J Director Sep 10 '24 Proposed Sale 225.84 5,000 1,129,210 Sep 10 02:27 PM Field Mark N Officer Sep 09 '24 Proposed Sale 220.87 1,383 305,465 Sep 09 04:50 PM Budden Lauren Officer Sep 09 '24 Proposed Sale 221.41 1,506 333,436 Sep 09 01:20 PM Singh Prem SVP, Global Operations Aug 30 '24 Sale 202.27 1,824 368,940 3,656 Sep 03 04:30 PM Singh Prem Officer Aug 30 '24 Proposed Sale 202.27 1,824 368,938 Aug 30 03:22 PM Chadwick Ana Maria EVP, CFO & Treasurer Aug 29 '24 Buy 206.00 100 20,600 13,314 Aug 29 04:17 PM Field Mark N SVP & Chief Technology Officer Aug 28 '24 Sale 203.00 1,387 281,561 11,347 Aug 29 04:14 PM Field Mark N Officer Aug 28 '24 Proposed Sale 203.00 1,387 281,561 Aug 28 04:02 PM Field Mark N SVP & Chief Technology Officer Jun 14 '24 Sale 199.96 1,500 299,940 12,875 Jun 17 04:11 PM Scannell Timothy J Director Jun 10 '24 Sale 190.51 7,000 1,333,570 35,586 Jun 11 04:12 PM Field Mark N SVP & Chief Technology Officer Jun 10 '24 Sale 190.43 2,131 405,806 14,375 Jun 11 04:11 PM BORIO LUCIANA Director Jun 04 '24 Sale 182.58 360 65,729 3,298 Jun 05 04:13 PM Scannell Timothy J Director May 28 '24 Option Exercise 32.33 18,267 590,595 45,886 May 29 04:04 PM Scannell Timothy J Director May 28 '24 Sale 180.90 3,300 596,970 42,586 May 29 04:04 PM Petrovic Shacey Director Feb 28 '24 Option Exercise 92.11 11,609 1,069,305 14,176 Feb 29 04:37 PM Petrovic Shacey Director Feb 28 '24 Sale 162.92 11,609 1,891,338 2,567 Feb 29 04:37 PM BORIO LUCIANA Director Dec 15 '23 Sale 207.08 72 14,910 2,278 Dec 18 04:01 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite